Microbiology Testing Market Analysis

Application (Pharmaceutical, Clinical, Food Testing, Energy, Chemical)

The pharmaceutical segment in the microbiology testing market is set to gain the largest revenue share of about 35% in the year 2037. The segment growth can be attributed to the increasing applications of microbiology testing in drug discovery, quality control and safety testing in the pharmaceutical industry. Moreover, rising R&D spending in the pharma sector is attributed to segment growth. For instance, each year, the pharma industry spends USD 100 billion on R&D.

Product (Instruments, Reagents)

The instruments segment is slated to hold about 57% share of the global microbiology testing market in the year 2037. The growth of the segment is impelled by the growing demand for rapid and automated testing methods, the increasing prevalence of infectious diseases, and the growing awareness about food safety and quality standards. Additionally, the growing demand for cost-effective methods for testing such as PCR, next-generation sequencing (NGS), and microarray-based testing and the increasing number of regulations mandating the testing in food, healthcare and other industries are also driving the instruments segment growth.

Our in-depth analysis of the global market includes the following segments:

Test Type	Bacterial Viral Fungal
Product	Instruments Reagents
Diseases	Respiratory Bloodstream Infections Gastrointestinal Sexually Transmitted Diseases Urinary Tract Infection Periodontal
Application	Pharmaceutical Clinical Food Testing Energy Chemical

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of microbiology testing is estimated at USD 4.84 billion.

The microbiology testing market size was valued at USD 4.59 billion in 2024 and is expected to cross USD 10.73 billion by the end of 2037, expanding at more than 6.9% CAGR during the forecast period i.e., between 2025-2037. Increasing prevalence of infectious diseases, the rising demand for rapid and cost-effective tests will boost the market growth.

North America industry is projected to hold a share of about 32% by 2037, on account of the rising prevalence of food-borne illnesses in the region.

The major players in the market include Neogen Corporation., STEMart, Masimo, Koninklijke Philips N.V., GE Healthcare, Cerner Corporation, Medtronic Plc, Stryker, iHealth Labs Inc., Cisco.

Microbiology Testing Market Analysis